Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Esophageal Squamous Cell Carcinoma 23Carcinoma, Hepatocellular 23Stomach Neoplasms 14Colorectal Neoplasms 13Liver Neoplasms 7Esophageal Neoplasms 6Rectal Neoplasms 5Pancreatic Neoplasms 4Cholangiocarcinoma 4Locally Advanced Rectal Cancer 3Biliary Tract Neoplasms 3Advanced Pancreatic Cancer 3Turcot syndrome 2Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Microsatellite Stable Metastatic Colorectal Cancer 2Klatskin Tumor 2Gallbladder Neoplasms 2Early Low Rectal Cancer 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma of the Stomach 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Carcinoma of Esophagus 1Sarcoma 1Radiotherapy 1Pathologic Complete Response 1Pancreatic Cancer Metastatic 1

Interventions

Capecitabine 20Oxaliplatin 13Irinotecan 8spartalizumab 6tislelizumab 4Radiation 4Neoadjuvant Therapy 4Immune Checkpoint Inhibitors 4Fluorouracil 4toripalimab 3sintilimab 2camrelizumab 2Radiotherapy 2Leucovorin 2Celecoxib 2veliparib 1peposertib 1nimotuzumab 1irinotecan sucrosofate 1XELOX 1Thymalfasin 1Radiotherapy, Intensity-Modulated 1Injections 1HMPL-013 1Folfox protocol 1Diathermy 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer × toripalimab × Gastrointestinal × Clear all
NCT06281405 2026-04-03

TORCH-iTNT

Fudan University

Phase 2 Recruiting
192 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT06840665 2025-02-21

MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer

Fudan University

Phase 2 Recruiting
46 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT04518280 2025-01-17

TORCH

Fudan University

Phase 2 Completed
130 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡